name1,name2,,,,
6-amino-2-n-pentylthiobenzothiazole,Clotrimazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.                                             ",
6-amino-2-n-pentylthiobenzothiazole,econazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.",
6-amino-2-n-pentylthiobenzothiazole,Itraconazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.                                             ",
6-amino-2-n-pentylthiobenzothiazole,Amorolfine,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.                                             ",
6-amino-2-n-pentylthiobenzothiazole,Terbinafine,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4. ",
acetic acid,Fluconazole,14693534,http://www.ncbi.nlm.nih.gov/pubmed/14693534,"Moosa MY, Sobel JD, Elhalis H, Du W, Akins RA. (2004) Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium. Antimicrob Agents Chemother. 48(1):161-7.",
albaconazole,Terbinafine,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Allicin,Fluconazole,19878317,http://www.ncbi.nlm.nih.gov/pubmed/19878317,"Guo N., Wu X.P., Yu L., Liu J.B., Meng R.Z., Jin J., Lu H.J., Wang X.L., Yan S.H., Deng X.M. (2010) In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods. Fems Immunology and Medical Microbiology 58:193-201. DOI: 10.1111/j.1574-695X.2009.00620.x.",
Alverine citrate,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
amiodarone,Fluconazole,20194694,http://www.ncbi.nlm.nih.gov/pubmed/ 20194694,"Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS. (2010) Mechanism of the synergistic effect ofand fluconazole in Candida albicans. Antimicrob Agents Chemother. 54(5):1753-61.",
amiodarone,Fluconazole,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles andagainst clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
amiodarone,Itraconazole,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles andagainst clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
amiodarone,Itraconazole,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
amiodarone,Voriconazole,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles andagainst clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
amiodarone,Micafungin,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Amitriptyline,Fluconazole,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Amorolfine,6-amino-2-n-pentylthiobenzothiazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"M¨²ckov¨¢ M, Bujd¨¢kov¨¢ H, Kuchta T. (2000) Synergy betweenand ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4. ",
Amphotericin B,rac-1-O-dodecylglycerol,7979283,http://www.ncbi.nlm.nih.gov/pubmed/ 7979283,"Haynes MP, Buckley HR, Higgins ML, Pieringer RA. (1994) Synergism between the antifungal agentsand alkyl glycerol ethers. Antimicrob Agents Chemother. 38(7):1523-9.",
Amphotericin B,Anidulafungin,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Amphotericin B,Azithromycin,9511049,http://www.ncbi.nlm.nih.gov/pubmed/ 9511049,"Clancy CJ, Nguyen MH. (1998) The combination ofand azithromycin as a potential new therapeutic approach to fusariosis. J Antimicrob Chemother. 41(1):127-30.",
Amphotericin B,Azithromycin,9447909,http://www.ncbi.nlm.nih.gov/pubmed/ 9447909,"Nguyen MH, Clancy CJ, Yu YC, Lewin AS. (1997) Potentiation of antifungal activity ofby azithromycin against Aspergillus species. Eur J Clin Microbiol Infect Dis. 16(11):846-8.",
Amphotericin B,Bupivacaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Amphotericin B,Caspofungin,19029317,http://www.ncbi.nlm.nih.gov/pubmed/ 19029317,"Kiraz N, Dag I, Yamac M, Kiremitci A, Kasifoglu N, Akgun Y. (2009) Antifungal activity of caspofungin in combination withagainst Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods. Antimicrob Agents Chemother. 53(2):788-90.",
Amphotericin B,Caspofungin,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Amphotericin B,Caspofungin,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Amphotericin B,Caspofungin,11751145,http://www.ncbi.nlm.nih.gov/pubmed/11751145,"Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. (2002) In vitro synergy of caspofungin andagainst Aspergillus and Fusarium spp. Antimicrob Agents Chemother. 46(1):245-7.",
Amphotericin B,Caspofungin acetate,9021188,http://www.ncbi.nlm.nih.gov/pubmed/ 9021188,"Franzot SP, Casadevall A. (1997) Pneumocandin L-743,872 enhances the activities ofand fluconazole against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother. 41(2):331-6.",
Amphotericin B,Caspofungin,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Amphotericin B,Cilofungin,1929290,http://www.ncbi.nlm.nih.gov/pubmed/ 1929290,"Hanson LH, Perlman AM, Clemons KV, Stevens DA. (1991) Synergy between cilofungin andin a murine model of candidiasis. Antimicrob Agents Chemother. 35(7):1334-7.",
Amphotericin B,Cilofungin,1759836,http://www.ncbi.nlm.nih.gov/pubmed/ 1759836,"Sugar AM, Goldani LZ, Picard M. (1991) Treatment of murine invasive candidiasis withand cilofungin: evidence for enhanced activity with combination therapy. Antimicrob Agents Chemother. 35(10):2128-30.",
Amphotericin B,Ciprofloxacin,18299413,http://www.ncbi.nlm.nih.gov/pubmed/ 18299413,"Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. (2008) Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother. 52(6):2196-204.",
Amphotericin B,Cyclosporine,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Amphotericin B,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Amphotericin B,Dodecapeptide,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
Amphotericin B,DU-6859a,7492096,http://www.ncbi.nlm.nih.gov/pubmed/ 7492096,"Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. (1995) In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination withand fluconazole against pathogenic fungi. Antimicrob Agents Chemother. 39(7):1517-21.",
Amphotericin B,ethambutol,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Amphotericin B,Flucytosine,16377675,http://www.ncbi.nlm.nih.gov/pubmed/ 16377675,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2006) Efficacy ofin combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 50(1):113-20.",
Amphotericin B,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Amphotericin B,Flucytosine,17043122,http://www.ncbi.nlm.nih.gov/pubmed/ 17043122,"Schwarz P, Janbon G, Dromer F, Lortholary O, Dannaoui E. (2007) Combination ofwith flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother. 51(1):383-5.",
Amphotericin B,Isoniazid,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Amphotericin B,lactoferrin,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Amphotericin B,Lidocaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Amphotericin B,Micafungin,16048969,http://www.ncbi.nlm.nih.gov/pubmed/16048969,"Yustes C, Guarro J. (2005) In vitro synergistic interaction betweenand micafungin against Scedosporium spp. Antimicrob Agents Chemother. 49(8):3498-500.",
Amphotericin B,Micafungin,15673724,http://www.ncbi.nlm.nih.gov/pubmed/ 15673724,"Serena C, Pastor FJ, Gilgado F, Mayayo E, Guarro J. (2005) Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother. 49(2):497-502.",
Amphotericin B,Micafungin,15980382,http://www.ncbi.nlm.nih.gov/pubmed/ 15980382,"Serena C, Fernï¿½ï¿½ndez-Torres B, Pastor FJ, Trilles L, Lazï¿½ï¿½ra Mdos S, Nolard N, Guarro J. (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother. 49(7):2994-6.",
Amphotericin B,Miconazole,7695271,http://www.ncbi.nlm.nih.gov/pubmed/ 7695271,"Maesaki S, Kohno S, Kaku M, Koga H, Hara K. (1994) Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother. 38(12):2843-5.",
Amphotericin B,Mycograb,12821470,http://www.ncbi.nlm.nih.gov/pubmed/ 12821470,"Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J. (2003) Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother. 47(7):2208-16.",
Amphotericin B,Mycograb,15629225,http://www.ncbi.nlm.nih.gov/pubmed/ 15629225,"Nooney L, Matthews RC, Burnie JP. (2005) Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. Diagn Microbiol Infect Dis. 51(1):19-29.",
Amphotericin B,Pentamidine,12234872,http://www.ncbi.nlm.nih.gov/pubmed/ 12234872,"Afeltra J, Dannaoui E, Meis JF, Rodriguez-Tudela JL, Verweij PE. (2002) In vitro synergistic interaction betweenand pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother. 46(10):3323-6.",
Amphotericin B,Posaconazole,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Amphotericin B,Posaconazole,18458135,http://www.ncbi.nlm.nih.gov/pubmed/18458135,"Perkhofer S, Locher M, Cuenca-Estrella M, Rï¿½ï¿½chel R, Wï¿½ï¿½rzner R, Dierich MP, Lass-Fl?rl C. (2008) Posaconazole enhances the activity ofagainst hyphae of zygomycetes in vitro. Antimicrob Agents Chemother. 52(7):2636-8.",
Amphotericin B,Posaconazole,15673745,http://www.ncbi.nlm.nih.gov/pubmed/ 15673745,"Cacciapuoti A, Gurnani M, Halpern J, Norris C, Patel R, Loebenberg D. (2005) Interaction between posaconazole andin concomitant treatment against Candida albicans in vivo. Antimicrob Agents Chemother. 49(2):638-42.",
Amphotericin B,Posaconazole,17116665,http://www.ncbi.nlm.nih.gov/pubmed/ 17116665,"Perkhofer S, Lugger H, Dierich MP, Lass-Fl?rl C. (2007) Posaconazole enhances the activity ofagainst Aspergillus hyphae in vitro. Antimicrob Agents Chemother. 51(2):791-3.",
Amphotericin B,rapamycin,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Amphotericin B,Rapamycin,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Amphotericin B,Ravuconazole,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
Amphotericin B,Rifabutin,9517924,http://www.ncbi.nlm.nih.gov/pubmed/ 9517924,"Clancy CJ, Yu YC, Lewin A, Nguyen MH. (1998) Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B. Antimicrob Agents Chemother. 42(3):509-13.",
Amphotericin B,FK506,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Amphotericin B,Terbinafine,12121963,http://www.ncbi.nlm.nih.gov/pubmed/ 12121963,"Dannaoui E, Afeltra J, Meis JF, Verweij PE; Eurofung Network. (2002) In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother. 46(8):2708-11.",
Amphotericin B,Voriconazole,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Amphotericin B,Voriconazole,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. Feb;31(2):171-4.",
Amphotericin B,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Amphotericin B,Micafungin,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Amphotericin B,Disulfiram,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Amphotericin B,Flucytosine,7047097,http://www.ncbi.nlm.nih.gov/pubmed/7047097,"Chen H.H., Liushih R.N., Hsieh W.C. (1982) Combined in vitro activity ofand 5-fluorocytosine against Cryptococcus neoformans and Candida albicans. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 15:106-12.",
Amphotericin B,Terbinafine,9511038,http://www.ncbi.nlm.nih.gov/pubmed/9511038,"Barchiesi F., Di Francesco L.F., Compagnucci P., Arzeni D., Giacometti A., Scalise G. (1998) In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. Journal of Antimicrobial Chemotherapy 41:59-65.",
Amphotericin B,Tetracycline,18310042,http://www.ncbi.nlm.nih.gov/pubmed/18310042,"Oliver B.G., Silver P.M., Marie C., Hoot S.J., Leyde S.E., White T.C. (2008) Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology-Sgm 154:960-970.",
Amphotericin B,Caspofungin,9021188,http://www.ncbi.nlm.nih.gov/pubmed/9021188,"Franzot S.P., Casadevall A. (1997) Pneumocandin L-743,872 enhances the activities ofand fluconazole against Cryptococcus neoformans in vitro. Antimicrobial Agents and Chemotherapy 41:331-336.",
Amphotericin B,Itraconazole,1309690,http://www.ncbi.nlm.nih.gov/pubmed/1309690,"Denning D.W., Hanson L.H., Perlman A.M., Stevens D.A. (1992) Invitro susceptibility and synergy studies of aspergillus species to conventional and new agents. Diagnostic Microbiology and Infectious Disease 15:21-34.",
Amphotericin B,Ketoconazole,6295266,http://www.ncbi.nlm.nih.gov/pubmed/6295266,"Odds F.C. (1982) Interactions among amphotericin-b, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi invitro. Antimicrobial Agents and Chemotherapy 22:763-770.",
Amphotericin B,FK506,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Amphotericin B,Rapamycin,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Amphotericin B,Cyclosporine A,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295 ,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Anidulafungin,Amphotericin B,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Anidulafungin,Cyclic peptide GS14K4,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin orwith antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56. Epub 2010 Jan 27.",
Anidulafungin,Dermaseptin S3,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin orwith antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56. Epub 2010 Jan 27.",
Anidulafungin,Fluconazole,12052624,http://www.ncbi.nlm.nih.gov/pubmed/12052624,"Roling EE, Klepser ME, Wasson A, Lewis RE, Ernst EJ, Pfaller MA. (2002) Antifungal activities of fluconazole, caspofungin (MK0991), and(LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. Diagn Microbiol Infect Dis. 43(1):13-7.",
Anidulafungin,Itraconazole,16048988,http://www.ncbi.nlm.nih.gov/pubmed/16048988,"Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. (2005) In vitro synergy testing ofwith itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 49(8):3572-4.",
Anidulafungin,Itraconazole,16414247,http://www.ncbi.nlm.nih.gov/pubmed/ 16414247,"Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP. (2006) In vitro interactions ofwith azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. Int J Antimicrob Agents. 27(2):174-7.",
Anidulafungin,Magainin 2,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin orwith antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Anidulafungin,Nikkomycin Z,10952614,http://www.ncbi.nlm.nih.gov/pubmed/ 10952614,Stevens DA. (2000) Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob Agents Chemother. 44(9):2547-8.,
Anidulafungin,Ranalexin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin orwith antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56. Epub 2010 Jan 27.",
Anidulafungin,Voriconazole,19995928,http://www.ncbi.nlm.nih.gov/pubmed/ 19995928,"Meletiadis J, Pournaras S, Roilides E, Walsh TJ. (2010) Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus. Antimicrob Agents Chemother. 54(2):602-9.",
Anidulafungin,Voriconazole,16048988,http://www.ncbi.nlm.nih.gov/pubmed/16048988,"Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. (2005) In vitro synergy testing ofwith itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 49(8):3572-4.",
Anidulafungin,Voriconazole,19307368,http://www.ncbi.nlm.nih.gov/pubmed/19307368,"Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. (2009) Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions betweenand voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother. 53(6):2382-91.",
Anidulafungin,Ravuconazole,18195067,http://www.ncbi.nlm.nih.gov/pubmed/18195067,"Cuenca-Estrella M., Alastruey-Lzquierdo A., Alcazar-Fuoli L., Bernal-Martinez L., Gomez-Lopez A., Buitrago M.J., Mellado E., Rodriguez-Tudela J.L. (2008) In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrobial Agents and Chemotherapy 52:1136-1139. DOI: 10.1128/aac.01160-07",
Atovaquone,Trimethoprim,9021174,http://www.ncbi.nlm.nih.gov/pubmed/ 9021174,"Walzer PD, Runck J, Orr S, Foy J, Steele P, White M. (1997) Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. Antimicrob Agents Chemother. 41(2):242-50.",
Azithromycin,Amphotericin B,9511049,http://www.ncbi.nlm.nih.gov/pubmed/ 9511049,"Clancy CJ, Nguyen MH. (1998) The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis. J Antimicrob Chemother. 41(1):127-30.",
Azithromycin,Amphotericin B,9447909,http://www.ncbi.nlm.nih.gov/pubmed/ 9447909,"Nguyen MH, Clancy CJ, Yu YC, Lewin AS. (1997) Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species. Eur J Clin Microbiol Infect Dis. 16(11):846-8.",
bacitracin,Rifampin,2039211,http://www.ncbi.nlm.nih.gov/pubmed/ 2039211,"Bacon AE, McGrath S, Fekety R, Holloway WJ. (1991) In vitro synergy studies with Clostridium difficile. Antimicrob Agents Chemother. 35(3):582-3.",
bafilomycin A1,Caspofungin,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
bafilomycin A1,FK506,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
Beauvericin,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Berberine,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Berberine,Fluconazole,16495278,http://www.ncbi.nlm.nih.gov/pubmed/16495278,"Quan H., Cao Y.Y., Xu Z., Zhao J.X., Gao P.H., Qin X.F., Jiang Y.Y. (2006) Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrobial Agents and Chemotherapy 50:1096-1099. DOI: 10.1128/aac.50.3.1096-1099.2006.",
Bifonazole,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Bifonazole,Nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Bupivacaine,Amphotericin B,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Bupivacaine,Caspofungin,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Bupivacaine,Itraconazole,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Bupivacaine,nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Calyculin A,Cantharidin,18622389,http://www.ncbi.nlm.nih.gov/pubmed/18622389,"Hoon S., Smith A.M., Wallace I.M., Suresh S., Miranda M., Fung E., Proctor M., Shokat K.M., Zhang C., Davis R.W., Giaever G., StOnge R.P., Nislow C. (2008) An integrated platform of genomic assays reveals small-molecule bioactivities. Nature Chemical Biology 4:498-506. DOI: 10.1038/nchembio.100.",
Cantharidin,Calyculin A,18622389,http://www.ncbi.nlm.nih.gov/pubmed/18622389,"Hoon S., Smith A.M., Wallace I.M., Suresh S., Miranda M., Fung E., Proctor M., Shokat K.M., Zhang C., Davis R.W., Giaever G., StOnge R.P., Nislow C. (2008) An integrated platform of genomic assays reveals small-molecule bioactivities. Nature Chemical Biology 4:498-506. DOI: 10.1038/nchembio.100.",
Caspofungin,Amphotericin B,19029317,http://www.ncbi.nlm.nih.gov/pubmed/ 19029317,"Kiraz N, Dag I, Yamac M, Kiremitci A, Kasifoglu N, Akgun Y. (2009) Antifungal activity ofin combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods. Antimicrob Agents Chemother. 53(2):788-90.",
Caspofungin,Amphotericin B,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Caspofungin,Amphotericin B,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Caspofungin,Amphotericin B,11751145,http://www.ncbi.nlm.nih.gov/pubmed/11751145,"Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. (2002) In vitro synergy ofand amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother. 46(1):245-7.",
Caspofungin,Bafilomycin A1,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
Caspofungin,Bupivacaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Caspofungin,Cyclic peptide 6752,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination ofor anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Caspofungin,Cyclic peptide GS14K4,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination ofor anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Caspofungin,Cyclosporine,15105118,http://www.ncbi.nlm.nih.gov/pubmed/15105118,"Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. (2004) In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 48(5):1664-9.",
Caspofungin,Dermaseptin S3,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination ofor anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Caspofungin,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Caspofungin,Flucytosine,14982791,http://www.ncbi.nlm.nih.gov/pubmed/ 14982791,"Dannaoui E, Lortholary O, Dromer F. (2004) In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 48(3):970-8.",
Caspofungin,Itraconazole,12654681,http://www.ncbi.nlm.nih.gov/pubmed/ 12654681,"Shalit I, Shadkchan Y, Samra Z, Osherov N. (2003) In vitro synergy ofand itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother. 47(4):1416-8.",
Caspofungin,Lidocaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Caspofungin,Magainin 2,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination ofor anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Caspofungin,Posaconazole,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Caspofungin,Posaconazole,16048980,http://www.ncbi.nlm.nih.gov/pubmed/ 16048980,"Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, Redding SW. (2005) In vitro interaction of posaconazole andagainst clinical isolates of Candida glabrata. Antimicrob Agents Chemother. 49(8):3544-5.",
Caspofungin,Posaconazole,17576835,http://www.ncbi.nlm.nih.gov/pubmed/17576835,"Guembe M, Guinea J, Pelï¿½ï¿½ez T, Torres-Narbona M, Bouza E. (2007) Synergistic effect of posaconazole andagainst clinical zygomycetes. Antimicrob Agents Chemother. 51(9):3457-8.",
Caspofungin,Ranalexin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination ofor anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Caspofungin,Staurosporine,15388447,http://www.ncbi.nlm.nih.gov/pubmed/ 15388447,"Markovich S, Yekutiel A, Shalit I, Shadkchan Y, Osherov N. (2004) Genomic approach to identification of mutations affectingsusceptibility in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 48(10):3871-6.",
Caspofungin,Sulfamethoxazole,15328085,http://www.ncbi.nlm.nih.gov/pubmed/15328085,"Yekutiel A, Shalit I, Shadkchan Y, Osherov N. (2004) In vitro activity ofcombined with sulfamethoxazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 48(9):3279-83.",
Caspofungin,FK506,15105118,http://www.ncbi.nlm.nih.gov/pubmed/15105118,"Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. (2004) In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 48(5):1664-9.",
Caspofungin,Terbinafine,15120736,http://www.ncbi.nlm.nih.gov/pubmed/ 15120736,"Gil-Lamaignere C, Mï¿½ï¿½ller FM. (2004) Differential effects of the combination ofand terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr. Int J Antimicrob Agents. 23(5):520-3.",
Caspofungin,Terbinafine,19289531,http://www.ncbi.nlm.nih.gov/pubmed/ 19289531,"Cavalheiro AS, Maboni G, de Azevedo MI, Argenta JS, Pereira DI, Spader TB, Alves SH, Santurio JM. (2009) In Vitro activity of terbinafine combined withand azoles against Pythium insidiosum. Antimicrob Agents Chemother. 53(5):2136-8.",
Caspofungin,Voriconazole,18299413,http://www.ncbi.nlm.nih.gov/pubmed/ 18299413,"Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. (2008) Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother. 52(6):2196-204.",
Caspofungin,Voriconazole,15728937,http://www.ncbi.nlm.nih.gov/pubmed/ 15728937,"Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL. (2005) Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 49(3):1232-5.",
Caspofungin,Voriconazole,20194697,http://www.ncbi.nlm.nih.gov/pubmed/ 20194697,"Kiraz N, Dag I, Yamac M, Kiremitci A, Kasifoglu N, Oz Y. (2010) Synergistic activities of three triazoles withagainst Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 54(5):2244-7.",
Caspofungin,Amphotericin B,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B,and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Caspofungin,Voriconazole,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B,and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Caspofungin,Itraconazole,12654681,http://www.ncbi.nlm.nih.gov/pubmed/12654681,"Shalit I., Shadkchan Y., Samra Z., Osherov N. (2003) In vitro synergy ofand itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrobial Agents and Chemotherapy 47:1416-1418. DOI: 10.1128/aac.47.4.1416-1418.2003.",
Caspofungin,Posaconazole,16048980,http://www.ncbi.nlm.nih.gov/pubmed/16048980,"Oliveira E.R., Fothergill A.W., Kirkpatrick W.R., Coco B.J., Patterson T.F., Redding S.W. (2005) In vitro interaction of posaconazole andagainst clinical isolates of Candida glabrata. Antimicrobial Agents and Chemotherapy 49:3544-3545. DOI: 10.1128/aac.49.8.3544-3545.2005.",
Caspofungin,Terbinafine,19289531,http://www.ncbi.nlm.nih.gov/pubmed/19289531,"Cavalheiro A.S., Maboni G., de Azevedo M.I., Argenta J.S., Pereira D.I.B., Spader T.B., Alves S.H., Santurio J.M. (2009) In Vitro Activity of Terbinafine Combined withand Azoles against Pythium insidiosum. Antimicrobial Agents and Chemotherapy 53:2136-2138. DOI: 10.1128/aac.01506-08.",
Caspofungin,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Caspofungin,Amphotericin B,9021188,http://www.ncbi.nlm.nih.gov/pubmed/9021188,"Franzot S.P., Casadevall A. (1997) Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrobial Agents and Chemotherapy 41:331-336.",
Caspofungin,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Caspofungin acetate,FK506,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
Caspofungin acetate,Amphotericin B,9021188,http://www.ncbi.nlm.nih.gov/pubmed/ 9021188,"Franzot SP, Casadevall A. (1997) Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother. 41(2):331-6.",
cetylpyridinium chloride,Fluconazole,15673785,http://www.ncbi.nlm.nih.gov/pubmed/15673785,"Edlind MP, Smith WL, Edlind TD. (2005) Effects of cetylpyridinium chloride resistance and treatment on fluconazole activity versus Candida albicans. Antimicrob Agents Chemother. 49(2):843-5.",
Chlorpromazine,Fluconazole,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Chlorpromazine,Ketoconazole,3391057,http://www.ncbi.nlm.nih.gov/pubmed/3391057,"Bengigi G., Polacheck I., Eilam Y. (1988) In vitro synergistic activity of ketoconazole with trifluoperazine and with chlorpromazine against medically important yeasts. Chemotherapy 34:96-100.",
ciclopirox,Ketoconazole,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Cilofungin,Amphotericin B,1929290,http://www.ncbi.nlm.nih.gov/pubmed/ 1929290,"Hanson LH, Perlman AM, Clemons KV, Stevens DA. (1991) Synergy between cilofungin and amphotericin B in a murine model of candidiasis. Antimicrob Agents Chemother. 35(7):1334-7.",
Cilofungin,Amphotericin B,1759836,http://www.ncbi.nlm.nih.gov/pubmed/ 1759836,"Sugar AM, Goldani LZ, Picard M. (1991) Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy. Antimicrob Agents Chemother. 35(10):2128-30.",
Ciprofloxacin,Amphotericin B,18299413,http://www.ncbi.nlm.nih.gov/pubmed/ 18299413,"Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. (2008) Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother. 52(6):2196-204.",
clarithromycin,Dapsone,9021174,http://www.ncbi.nlm.nih.gov/pubmed/ 9021174,"Walzer PD, Runck J, Orr S, Foy J, Steele P, White M. (1997) Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. Antimicrob Agents Chemother. 41(2):242-50.",
Clomipramine,Fluconazole,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Clotrimazole,6-amino-2-n-pentylthiobenzothiazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"Mï¿½ï¿½ckovï¿½ï¿½ M, Bujdï¿½ï¿½kovï¿½ï¿½ H, Kuchta T. (2000) Synergy between 6-amino-2-n-pentylthiobenzothiazole and ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.",
Clotrimazole,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Clotrimazole,nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
cyclic peptide 6752,Caspofungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
cyclic peptide GS14K4,Anidulafungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
cyclic peptide GS14K4,Caspofungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Cyclosporine,Amphotericin B,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Cyclosporine,Amphotericin B,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Cyclosporine,Caspofungin,15105118,http://www.ncbi.nlm.nih.gov/pubmed/15105118,"Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. (2004) In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 48(5):1664-9.",
Cyclosporine,Fluconazole,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Cyclosporine,Itraconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Cyclosporine,Posaconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Cyclosporine,ravuconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Cyclosporine A,Amphotericin B,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Cyclosporine A,Itraconazole,18194958,http://www.ncbi.nlm.nih.gov/pubmed/18194958,"Li Y., Sun S.J., Guo Q.J., Ma L., Shi C.W., Su L.Q., Li H.J. (2008) In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. Journal of Antimicrobial Chemotherapy 61:577-585. DOI: 10.1093/jac/dkm493.",
Cyclosporine A,Fenpropimorph,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Cyclosporine A,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Cyclosporine A,Tunicamycin,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Cyclosporine A,Voriconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Cyclosporine A,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Cyclosporine A,Posaconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Cyclosporine A,Ravuconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Dacarbazine,Phenazopyridine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Dacarbazine,Estradiol,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Dacarbazine,Tamoxifen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Dacarbazine,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
dapsone,Clarithromycin,9021174,http://www.ncbi.nlm.nih.gov/pubmed/ 9021174,"Walzer PD, Runck J, Orr S, Foy J, Steele P, White M. (1997) Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. Antimicrob Agents Chemother. 41(2):242-50.",
Defensin NP-1,Fluconazole,8109927,http://www.ncbi.nlm.nih.gov/pubmed/8109927,"Alcouloumre MS, Ghannoum MA, Ibrahim AS, Selsted ME, Edwards JE Jr. (1993) Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother. 37(12):2628-32.",
deferiprone,Fluconazole,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
deferiprone,Ketoconazole,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Dermaseptin S3,Anidulafungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Dermaseptin S3,Caspofungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Disulfiram,Amphotericin B,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Disulfiram,Ketoconazole,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
dodecapeptide,Amphotericin B,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
dodecapeptide,Fluconazole,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
dodecapeptide,Itraconazole,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
doxycycline,Fluconazole,19515537,http://www.ncbi.nlm.nih.gov/pubmed/ 19515537,"Miceli MH, Bernardo SM, Lee SA. (2009) In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents. 34(4):326-32.",
DU-6859a,Amphotericin B,7492096,http://www.ncbi.nlm.nih.gov/pubmed/ 7492096,"Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. (1995) In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother. 39(7):1517-21.",
DU-6859a,Fluconazole,7492096,http://www.ncbi.nlm.nih.gov/pubmed/ 7492096,"Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. (1995) In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother. 39(7):1517-21.",
econazole,6-amino-2-n-pentylthiobenzothiazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"Mï¿½ï¿½ckovï¿½ï¿½ M, Bujdï¿½ï¿½kovï¿½ï¿½ H, Kuchta T. (2000) Synergy between 6-amino-2-n-pentylthiobenzothiazole and ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.",
econazole,Ibuprofen,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
econazole,Nikkomycin Z,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
Estradiol,Dacarbazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
ethambutol,Amphotericin B,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
ethambutol,Fluconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
ethambutol,Itraconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
ethambutol,Ketoconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
ethambutol,Voriconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Eugenol,Fluconazole,20634332,http://www.ncbi.nlm.nih.gov/pubmed/20634332,"Ahmad A., Khan A., Khan L.A., Manzoor N. (2010) In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. Journal of Medical Microbiology 59:1178-1184. DOI: 10.1099/jmm.0.020693-0",
Fenpropimorph,Cyclosporine A,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fenpropimorph,FK506,12604527,http://www.ncbi.nlm.nih.gov/pubmed/12604527,"Onyewu C., Blankenship J.R., Del Poeta M., Heitman J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrobial Agents and Chemotherapy 47:956-964. DOI: 10.1128/aac.47.3.956-964.2003.",
Fenpropimorph,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
FK506,Amphotericin B,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
FK506,Bafilomycin A1,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitorsand L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
FK506,Caspofungin,15105118,http://www.ncbi.nlm.nih.gov/pubmed/15105118,"Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. (2004) In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 48(5):1664-9.",
FK506,Caspofungin acetate,10681348,http://www.ncbi.nlm.nih.gov/pubmed/ 10681348,"Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. (2000) Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitorsand L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 44(3):739-46.",
FK506,Fluconazole,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
FK506,Amphotericin B,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
FK506,Fenpropimorph,12604527,http://www.ncbi.nlm.nih.gov/pubmed/12604527,"Onyewu C., Blankenship J.R., Del Poeta M., Heitman J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrobial Agents and Chemotherapy 47:956-964. DOI: 10.1128/aac.47.3.956-964.2003.",
FK506,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
FK506,Itraconazole,18056277,http://www.ncbi.nlm.nih.gov/pubmed/18056277,"Sun S., Li Y., Guo Q.J., Shi C.W., Yu J.L., Ma L. (2008) In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods. Antimicrobial Agents and Chemotherapy 52:409-417. DOI: 10.1128/aac.01070-07.",
FK506,Terbinafine,12604527,http://www.ncbi.nlm.nih.gov/pubmed/12604527,"Onyewu C., Blankenship J.R., Del Poeta M., Heitman J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrobial Agents and Chemotherapy 47:956-964. DOI: 10.1128/aac.47.3.956-964.2003.",
FK506,Tunicamycin,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
FK506,Voriconazole,18056277,http://www.ncbi.nlm.nih.gov/pubmed/18056277,"Sun S., Li Y., Guo Q.J., Shi C.W., Yu J.L., Ma L. (2008) In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods. Antimicrobial Agents and Chemotherapy 52:409-417. DOI: 10.1128/aac.01070-07.",
FK506,Ravuconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Fluconazole,Acetic acid,14693534,http://www.ncbi.nlm.nih.gov/pubmed/14693534,"Moosa MY, Sobel JD, Elhalis H, Du W, Akins RA. (2004) Fungicidal activity ofagainst Candida albicans in a synthetic vagina-simulative medium. Antimicrob Agents Chemother. 48(1):161-7.",
Fluconazole,Amiodarone,20194694,http://www.ncbi.nlm.nih.gov/pubmed/ 20194694,"Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS. (2010) Mechanism of the synergistic effect of amiodarone andin Candida albicans. Antimicrob Agents Chemother. 54(5):1753-61.",
Fluconazole,Amiodarone,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles and amiodarone against clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
Fluconazole,Anidulafungin,12052624,http://www.ncbi.nlm.nih.gov/pubmed/12052624,"Roling EE, Klepser ME, Wasson A, Lewis RE, Ernst EJ, Pfaller MA. (2002) Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. Diagn Microbiol Infect Dis. 43(1):13-7.",
Fluconazole,Cetylpyridinium chloride,15673785,http://www.ncbi.nlm.nih.gov/pubmed/15673785,"Edlind MP, Smith WL, Edlind TD. (2005) Effects of cetylpyridinium chloride resistance and treatment onactivity versus Candida albicans. Antimicrob Agents Chemother. 49(2):843-5.",
Fluconazole,Cyclosporine,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Fluconazole,Defensin NP-1,8109927,http://www.ncbi.nlm.nih.gov/pubmed/8109927,"Alcouloumre MS, Ghannoum MA, Ibrahim AS, Selsted ME, Edwards JE Jr. (1993) Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob Agents Chemother. 37(12):2628-32.",
Fluconazole,Deferiprone,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Fluconazole,Dodecapeptide,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
Fluconazole,Doxycycline,19515537,http://www.ncbi.nlm.nih.gov/pubmed/ 19515537,"Miceli MH, Bernardo SM, Lee SA. (2009) In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents. 34(4):326-32.",
Fluconazole,DU-6859a,7492096,http://www.ncbi.nlm.nih.gov/pubmed/ 7492096,"Nakajima R, Kitamura A, Someya K, Tanaka M, Sato K. (1995) In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B andagainst pathogenic fungi. Antimicrob Agents Chemother. 39(7):1517-21.",
Fluconazole,Ethambutol,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Fluconazole,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Fluconazole,Flucytosine,7486902,http://www.ncbi.nlm.nih.gov/pubmed/ 7486902,"Nguyen MH, Barchiesi F, McGough DA, Yu VL, Rinaldi MG. (1995) In vitro evaluation of combination ofand flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother. 39(8):1691-5.",
Fluconazole,Fluvastatin,9087504,http://www.ncbi.nlm.nih.gov/pubmed/ 9087504,"Chin NX, Weitzman I, Della-Latta P. (1997) In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother. 41(4):850-2.",
Fluconazole,Ibuprofen,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy withand either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
Fluconazole,Lactoferrin-derived peptide hLF,12499200,http://www.ncbi.nlm.nih.gov/pubmed/ 12499200,"Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH. (2003) Synergistic activity of the N-terminal peptide of human lactoferrin andagainst Candida species. Antimicrob Agents Chemother. 47(1):262-7.",
Fluconazole,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Fluconazole,Nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Fluconazole,nitric oxide,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
Fluconazole,Propylparaben,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy withand either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
Fluconazole,Pyrazinamide,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Fluconazole,Rapamycin,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Fluconazole,Sodium Salicylate,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy withand either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
Fluconazole,FK506,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
Fluconazole,Terbinafine,19289531,http://www.ncbi.nlm.nih.gov/pubmed/ 19289531,"Cavalheiro AS, Maboni G, de Azevedo MI, Argenta JS, Pereira DI, Spader TB, Alves SH, Santurio JM. (2009) In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum. Antimicrob Agents Chemother. 53(5):2136-8.",
Fluconazole,Allicin,19878317,http://www.ncbi.nlm.nih.gov/pubmed/19878317,"Guo N., Wu X.P., Yu L., Liu J.B., Meng R.Z., Jin J., Lu H.J., Wang X.L., Yan S.H., Deng X.M. (2010) In vitro and in vivo interactions betweenand allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods. Fems Immunology and Medical Microbiology 58:193-201. DOI: 10.1111/j.1574-695X.2009.00620.x.",
Fluconazole,Alverine citrate,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fluconazole,Amitriptyline,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination ofand cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Fluconazole,Berberine,16495278,http://www.ncbi.nlm.nih.gov/pubmed/16495278,"Quan H., Cao Y.Y., Xu Z., Zhao J.X., Gao P.H., Qin X.F., Jiang Y.Y. (2006) Potent in vitro synergism ofand berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrobial Agents and Chemotherapy 50:1096-1099. DOI: 10.1128/aac.50.3.1096-1099.2006.",
Fluconazole,Caspofungin,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fluconazole,Chlorpromazine,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination ofand cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Fluconazole,Clomipramine,10952582,http://www.ncbi.nlm.nih.gov/pubmed/10952582,"Marchetti O., Moreillon P., Glauser M.P., Bille J., Sanglard D. (2000) Potent synergism of the combination ofand cyclosporine in Candida albicans. Antimicrobial Agents and Chemotherapy 44:2373-2381.",
Fluconazole,Fenpropimorph,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fluconazole,Flucytosine,9145879,http://www.ncbi.nlm.nih.gov/pubmed/9145879,"Nguyen M.H., Najvar L.K., Yu C.Y., Graybill J.R. (1997) Combination therapy withand flucytosine in the murine model of Cryptococcal meningitis. Antimicrobial Agents and Chemotherapy 41:1120-1123.",
Fluconazole,Latrunculin A,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fluconazole,Lovastatin,14653518,Link:,http://www.ncbi.nlm.nih.gov/pubmed/14653518,"Song J.L., Lyons C.N., Holleman S., Oliver B.G., White T.C. (2003) Antifungal activity ofin combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Medical Mycology 41:417-425. DOI: 10.1080/1369378031000137233."
Fluconazole,Micafungin,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"NISHI I., SUNADA A., TOYOKAWA M., et al. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species",
Fluconazole,Ofloxacin,11810556,http://www.ncbi.nlm.nih.gov/pubmed/11810556,"Sasaki E., Maesaki S., Miyazaki Y., Yanagihara K., Tomono K., Tashiro T., Kohno S. (2000) Synergistic effect of ofloxacin andagainst azole-resistant Candida albicans. J Infect Chemother 6:151-4.",
Fluconazole,Phenazopyridine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Fluconazole,Retigeric acid B,19171796,http://www.ncbi.nlm.nih.gov/pubmed/19171796,"Sun L.M., Sun S.J., Cheng A.X., Wu X.Z., Zhang Y., Lou H.X. (2009) In Vitro Activities of Retigeric Acid B Alone and in Combination with Azole Antifungal Agents against Candida albicans. Antimicrobial Agents and Chemotherapy 53:1586-1591. DOI: 10.1128/aac.00940-08.",
Fluconazole,Terbinafine,17332758,http://www.ncbi.nlm.nih.gov/pubmed/17332758,"Lehar J., Zimmermann G.R., Krueger A.S., Molnar R.A., Ledell J.T., Heilbut A.M., Short G.F., Giusti L.C., Nolan G.P., Magid O.A., Lee M.S., Borisy A.A., Stockwell B.R., Keith C.T. (2007) Chemical combination effects predict connectivity in biological systems. Molecular Systems Biology 3. DOI: 10.1038/msb4100116.",
Fluconazole,Wortmannin,17332758,http://www.ncbi.nlm.nih.gov/pubmed/17332758,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Fluconazole,Methyleugenol,20634332,http://www.ncbi.nlm.nih.gov/pubmed/20634332,"Ahmad A., Khan A., Khan L.A., Manzoor N. (2010) In vitro synergy of eugenol and methyleugenol withagainst clinical Candida isolates. Journal of Medical Microbiology 59:1178-1184. DOI: 10.1099/jmm.0.020693-0",
Fluconazole,Eugenol,20634332,http://www.ncbi.nlm.nih.gov/pubmed/20634332,"Ahmad A., Khan A., Khan L.A., Manzoor N. (2010) In vitro synergy of eugenol and methyleugenol withagainst clinical Candida isolates. Journal of Medical Microbiology 59:1178-1184. DOI: 10.1099/jmm.0.020693-0",
Fluconazole,Cyclosporine A,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Flucytosine,Amphotericin B,16377675,http://www.ncbi.nlm.nih.gov/pubmed/ 16377675,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2006) Efficacy of amphotericin B in combination withagainst flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 50(1):113-20.",
Flucytosine,Amphotericin B,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Flucytosine,Amphotericin B,17043122,http://www.ncbi.nlm.nih.gov/pubmed/ 17043122,"Schwarz P, Janbon G, Dromer F, Lortholary O, Dannaoui E. (2007) Combination of amphotericin B withis active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother. 51(1):383-5.",
Flucytosine,Caspofungin,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Flucytosine,Caspofungin,14982791,http://www.ncbi.nlm.nih.gov/pubmed/ 14982791,"Dannaoui E, Lortholary O, Dromer F. (2004) In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 48(3):970-8.",
Flucytosine,Fluconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Flucytosine,Fluconazole,7486902,http://www.ncbi.nlm.nih.gov/pubmed/ 7486902,"Nguyen MH, Barchiesi F, McGough DA, Yu VL, Rinaldi MG. (1995) In vitro evaluation of combination of fluconazole andagainst Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother. 39(8):1691-5.",
Flucytosine,Itraconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Flucytosine,Posaconazole,11302795,http://www.ncbi.nlm.nih.gov/pubmed/ 11302795,"Barchiesi F, Schimizzi AM, Najvar LK, Bocanegra R, Caselli F, Di Cesare S, Giannini D, Di Francesco LF, Giacometti A, Carle F, Scalise G, Graybill JR. (2001) Interactions of posaconazole andagainst Cryptococcus neoformans. Antimicrob Agents Chemother. 45(5):1355-9.",
Flucytosine,Voriconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Flucytosine,Fluconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Flucytosine,Amphotericin B,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Flucytosine,Voriconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Flucytosine,Caspofungin,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Flucytosine,Itraconazole,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction ofwith conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Flucytosine,Micafungin,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Fluvastatin,Fluconazole,9087504,http://www.ncbi.nlm.nih.gov/pubmed/ 9087504,"Chin NX, Weitzman I, Della-Latta P. (1997) In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother. 41(4):850-2.",
Fluvastatin,Itraconazole,9087504,http://www.ncbi.nlm.nih.gov/pubmed/ 9087504,"Chin NX, Weitzman I, Della-Latta P. (1997) In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother. 41(4):850-2.",
Geldanamycin,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Haloprogin,Pentolinium,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
ibuprofen,Econazole,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, andagainst Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
ibuprofen,Fluconazole,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
ibuprofen,Miconazole,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
ibuprofen,Nikkomycin X,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, andagainst Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
ibuprofen,Econazole,8592989,http://www.ncbi.nlm.nih.gov/pubmed/8592989,"Tariq V.N., Scott E.M., McCain N.E. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, andagainst Candida albicans in vitro. Antimicrobial Agents and Chemotherapy 39:2615-2619",
ibuprofen,Nikkomycin Z,8592989,http://www.ncbi.nlm.nih.gov/pubmed/8592989,"Tariq V.N., Scott E.M., McCain N.E. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, andagainst Candida albicans in vitro. Antimicrobial Agents and Chemotherapy 39:2615-2619",
isoniazid,Amphotericin B,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
isoniazid,Itraconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Itraconazole,6-amino-2-n-pentylthiobenzothiazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"Mï¿½ï¿½ckovï¿½ï¿½ M, Bujdï¿½ï¿½kovï¿½ï¿½ H, Kuchta T. (2000) Synergy between 6-amino-2-n-pentylthiobenzothiazole and ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.",
Itraconazole,Amiodarone,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles and amiodarone against clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
Itraconazole,Amiodarone,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds andagainst clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
Itraconazole,Anidulafungin,16048988,http://www.ncbi.nlm.nih.gov/pubmed/16048988,"Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. (2005) In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 49(8):3572-4.",
Itraconazole,Anidulafungin,16414247,http://www.ncbi.nlm.nih.gov/pubmed/ 16414247,"Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP. (2006) In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. Int J Antimicrob Agents. 27(2):174-7.",
Itraconazole,Bupivacaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Itraconazole,Caspofungin,12654681,http://www.ncbi.nlm.nih.gov/pubmed/ 12654681,"Shalit I, Shadkchan Y, Samra Z, Osherov N. (2003) In vitro synergy of caspofungin andagainst Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother. 47(4):1416-8.",
Itraconazole,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Itraconazole,Dodecapeptide,17156978,http://www.ncbi.nlm.nih.gov/pubmed/ 17156978,"Duggineni S, Srivastava G, Kundu B, Kumar M, Chaturvedi AK, Shukla PK. (2007) A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents. Int J Antimicrob Agents. 29(1):73-8.",
Itraconazole,Ethambutol,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Itraconazole,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Itraconazole,Fluvastatin,9087504,http://www.ncbi.nlm.nih.gov/pubmed/ 9087504,"Chin NX, Weitzman I, Della-Latta P. (1997) In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole andagainst Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother. 41(4):850-2.",
Itraconazole,Isoniazid,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Itraconazole,Lansoprazole,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds andagainst clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
Itraconazole,Lidocaine,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Itraconazole,Micafungin,18762407,http://www.ncbi.nlm.nih.gov/pubmed/ 18762407,"Ruï¿½ï¿½z-Cendoya M, Rodriguez MM, Marinï¿½ï¿½ M, Pastor FJ, Guarro J. (2008) In vitro interactions ofand micafungin against clinically important filamentous fungi. Int J Antimicrob Agents. 32(5):418-20.",
Itraconazole,Micafungin,17698327,http://www.ncbi.nlm.nih.gov/pubmed/ 17698327,"Marinï¿½ï¿½ M, Serena C, Pastor J, Quindï¿½ï¿½s G, Carrillo AJ, Guarro J. (2007) In vitro activity of micafungin combined withagainst Candida spp. Int J Antimicrob Agents. 30(5):463-5.",
Itraconazole,Nifedipine,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds andagainst clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
Itraconazole,Nikkomycin Z,10348760,http://www.ncbi.nlm.nih.gov/pubmed/ 10348760,"Li RK, Rinaldi MG. (1999) In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother. 43(6):1401-5.",
Itraconazole,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Itraconazole,Nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Itraconazole,Pyrazinamide,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Itraconazole,Terbinafine,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Itraconazole,Terbinafine,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. 31(2):171-4.",
Itraconazole,Terbinafine,12663160,http://www.ncbi.nlm.nih.gov/pubmed/12663160,"Dunn JJ, Billetdeaux E, Skodack-Jones L, Carroll KC. (2003) Evaluation of three Copan viral transport systems for the recovery of cultivatable, clinical virus isolates. Diagn Microbiol Infect Dis. 45(3):191-7.",
Itraconazole,Terbinafine,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Itraconazole,Terbinafine,10639389,http://www.ncbi.nlm.nih.gov/pubmed/ 10639389,"Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. (2000) In vitro interaction of terbinafine withagainst clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 44(2):470-2.",
Itraconazole,Terbinafine,11850251,http://www.ncbi.nlm.nih.gov/pubmed/11850251,"Te Dorsthorst DT, Verweij PE, Meis JF, Punt NC, Mouton JW. (2002) Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother. 46(3):702-7.",
Itraconazole,Voriconazole,15855543,http://www.ncbi.nlm.nih.gov/pubmed/ 15855543,"Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. (2005) Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother. 49(5):2119-21.",
Itraconazole,Amphotericin B,1309690,http://www.ncbi.nlm.nih.gov/pubmed/1309690,"Denning D.W., Hanson L.H., Perlman A.M., Stevens D.A. (1992) Invitro susceptibility and synergy studies of aspergillus species to conventional and new agents. Diagnostic Microbiology and Infectious Disease 15:21-34.",
Itraconazole,Flucytosine,10459811,http://www.ncbi.nlm.nih.gov/pubmed/10459811,"Barchiesi F., Gallo D., Caselli F., Di Francesco L.F., Arzeni D., Giacometti A., Scalise G. (1999) In-vitro interactions ofwith flucytosine against clinical isolates of Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy 44:65-70.",
Itraconazole,Micafungin,18762407,http://www.ncbi.nlm.nih.gov/pubmed/18762407,"Ruiz-Cendoya M., Rodriguez M.M., Marine M., Pastor F.J., Guarro J. (2008) In vitro interactions ofand micafungin against clinically important filamentous fungi. International Journal of Antimicrobial Agents 32:418-420. DOI: 10.1016/j.ijantimicag.2008.05.015.",
Itraconazole,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Itraconazole,Tacrolimus,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Itraconazole,Rapamycin,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Itraconazole,Terbinafine,10459811,http://www.ncbi.nlm.nih.gov/pubmed/10459811,"Barchiesi F., Gallo D., Caselli F., Di Francesco L.F., Arzeni D., Giacometti A., Scalise G. (1999) In-vitro interactions ofwith flucytosine against clinical isolates of Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy 44:65-70.",
Itraconazole,Cyclosporine A,18194958,http://www.ncbi.nlm.nih.gov/pubmed/18194958,"Li Y., Sun S.J., Guo Q.J., Ma L., Shi C.W., Su L.Q., Li H.J. (2008) In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. Journal of Antimicrobial Chemotherapy 61:577-585. DOI: 10.1093/jac/dkm493.",
Itraconazole,FK506,18056277,http://www.ncbi.nlm.nih.gov/pubmed/18056277,"Sun S., Li Y., Guo Q.J., Shi C.W., Yu J.L., Ma L. (2008) In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods. Antimicrobial Agents and Chemotherapy 52:409-417. DOI: 10.1128/aac.01070-07.",
Ketoconazole,Ciclopirox,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Ketoconazole,Deferiprone,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
Ketoconazole,Ethambutol,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Ketoconazole,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Ketoconazole,Nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Ketoconazole,nitric oxide,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
Ketoconazole,Amphotericin B,6295266,http://www.ncbi.nlm.nih.gov/pubmed/6295266,"Odds F.C. (1982) Interactions among amphotericin-b, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi invitro. Antimicrobial Agents and Chemotherapy 22:763-770.",
Ketoconazole,Beauvericin,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Berberine,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Chlorpromazine,3391057,http://www.ncbi.nlm.nih.gov/pubmed/3391057,"Bengigi G., Polacheck I., Eilam Y. (1988) In vitro synergistic activity ofwith trifluoperazine and with chlorpromazine against medically important yeasts. Chemotherapy 34:96-100.",
Ketoconazole,Cyclosporine A,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Disulfiram,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Ketoconazole,Geldanamycin,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Lovastatin,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Ketoconazole,Radicicol,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ketoconazole,Retigeric acid B,19171796,http://www.ncbi.nlm.nih.gov/pubmed/19171796,"Sun L.M., Sun S.J., Cheng A.X., Wu X.Z., Zhang Y., Lou H.X. (2009) In Vitro Activities of Retigeric Acid B Alone and in Combination with Azole Antifungal Agents against Candida albicans. Antimicrobial Agents and Chemotherapy 53:1586-1591. DOI: 10.1128/aac.00940-08.",
Ketoconazole,Ribavirin,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Ketoconazole,Terbinafine,12499177,http://www.ncbi.nlm.nih.gov/pubmed/12499177,"Meletiadis J., Mouton J.W., Meis J., Verweij P.E. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates. Antimicrobial Agents and Chemotherapy 47:106-117. DOI: 10.1128/aac.47.1.106-117.2003.",
lactoferrin,Amphotericin B,19307370,http://www.ncbi.nlm.nih.gov/pubmed/ 19307370,"Zarember KA, Cruz AR, Huang CY, Gallin JI. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother. 53(6):2654-6.",
lactoferrin-derived peptide hLF,Fluconazole,12499200,http://www.ncbi.nlm.nih.gov/pubmed/ 12499200,"Lupetti A, Paulusma-Annema A, Welling MM, Dogterom-Ballering H, Brouwer CP, Senesi S, Van Dissel JT, Nibbering PH. (2003) Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother. 47(1):262-7.",
lansoprazole,Itraconazole,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
Latrunculin A,Fluconazole,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Lidocaine,Amphotericin B,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Lidocaine,Caspofungin,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Lidocaine,Itraconazole,16527460,http://www.ncbi.nlm.nih.gov/pubmed/ 16527460,"Rodrigues AG, Araujo R, Pina-Vaz C. (2006) Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus. Int J Antimicrob Agents. 27(4):339-43.",
Lovastatin,Voriconazole,16377673,http://www.ncbi.nlm.nih.gov/pubmed/ 16377673,"Chamilos G, Lewis RE, Kontoyiannis DP. (2006) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 50(1):96-103.",
Lovastatin,Fluconazole,14653518,http://www.ncbi.nlm.nih.gov/pubmed/14653518,"Song J.L., Lyons C.N., Holleman S., Oliver B.G., White T.C. (2003) Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Medical Mycology 41:417-425. DOI: 10.1080/1369378031000137233.",
Lovastatin,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Magainin 2,Anidulafungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Magainin 2,Caspofungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Methoxsalen,Tamoxifen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Methyleugenol,Fluconazole,20634332,http://www.ncbi.nlm.nih.gov/pubmed/20634332,"Ahmad A., Khan A., Khan L.A., Manzoor N. (2010) In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. Journal of Medical Microbiology 59:1178-1184. DOI: 10.1099/jmm.0.020693-0",
Micafungin,Amphotericin B,16048969,http://www.ncbi.nlm.nih.gov/pubmed/16048969,"Yustes C, Guarro J. (2005) In vitro synergistic interaction between amphotericin B andagainst Scedosporium spp. Antimicrob Agents Chemother. 49(8):3498-500.",
Micafungin,Amphotericin B,15673724,http://www.ncbi.nlm.nih.gov/pubmed/ 15673724,"Serena C, Pastor FJ, Gilgado F, Mayayo E, Guarro J. (2005) Efficacy ofin combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother. 49(2):497-502.",
Micafungin,Amphotericin B,15980382,http://www.ncbi.nlm.nih.gov/pubmed/ 15980382,"Serena C, Fernï¿½ï¿½ndez-Torres B, Pastor FJ, Trilles L, Lazï¿½ï¿½ra Mdos S, Nolard N, Guarro J. (2005) In vitro interactions ofwith other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother. 49(7):2994-6.",
Micafungin,Itraconazole,18762407,http://www.ncbi.nlm.nih.gov/pubmed/ 18762407,"Ruï¿½ï¿½z-Cendoya M, Rodriguez MM, Marinï¿½ï¿½ M, Pastor FJ, Guarro J. (2008) In vitro interactions of itraconazole andagainst clinically important filamentous fungi. Int J Antimicrob Agents. 32(5):418-20.",
Micafungin,Itraconazole,17698327,http://www.ncbi.nlm.nih.gov/pubmed/ 17698327,"Marinï¿½ï¿½ M, Serena C, Pastor J, Quindï¿½ï¿½s G, Carrillo AJ, Guarro J. (2007) In vitro activity ofcombined with itraconazole against Candida spp. Int J Antimicrob Agents. 30(5):463-5.",
Micafungin,Nikkomycin Z,17325217,http://www.ncbi.nlm.nih.gov/pubmed/ 17325217,"Brun YF, Dennis CG, Greco WR, Bernacki RJ, Pera PJ, Bushey JJ, Youn RC, White DB, Segal BH. (2007) Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm. Antimicrob Agents Chemother. 51(5):1804-12.",
Micafungin,Nikkomycin Z,11709302,http://www.ncbi.nlm.nih.gov/pubmed/ 11709302,"Chiou CC, Mavrogiorgos N, Tillem E, Hector R, Walsh TJ. (2001) Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob Agents Chemother. 45(12):3310-21.",
Micafungin,Voriconazole,16304192,http://www.ncbi.nlm.nih.gov/pubmed/16304192,"Heyn K, Tredup A, Salvenmoser S, Mï¿½ï¿½ller FM. (2005) Effect of voriconazole combined withagainst Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother. 49(12):5157-9.",
Micafungin,Voriconazole,15980382,http://www.ncbi.nlm.nih.gov/pubmed/ 15980382,"Serena C, Fernï¿½ï¿½ndez-Torres B, Pastor FJ, Trilles L, Lazï¿½ï¿½ra Mdos S, Nolard N, Guarro J. (2005) In vitro interactions ofwith other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother. 49(7):2994-6.",
Micafungin,Amiodarone,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Micafungin,Flucytosine,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Micafungin,Amphotericin B,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Micafungin,Fluconazole,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Micafungin,Itraconazole,18762407,http://www.ncbi.nlm.nih.gov/pubmed/18762407,"Ruiz-Cendoya M., Rodriguez M.M., Marine M., Pastor F.J., Guarro J. (2008) In vitro interactions of itraconazole andagainst clinically important filamentous fungi. International Journal of Antimicrobial Agents 32:418-420. DOI: 10.1016/j.ijantimicag.2008.05.015.",
Micafungin,Voriconazole,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects ofwith fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Miconazole,Amphotericin B,7695271,http://www.ncbi.nlm.nih.gov/pubmed/ 7695271,"Maesaki S, Kohno S, Kaku M, Koga H, Hara K. (1994) Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother. 38(12):2843-5.",
Miconazole,Ibuprofen,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
Miconazole,nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Miconazole,nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
Miconazole,nitric oxide,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
Miconazole,Terbinafine,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Mycograb,Amphotericin B,12821470,http://www.ncbi.nlm.nih.gov/pubmed/ 12821470,"Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J. (2003) Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother. 47(7):2208-16.",
Mycograb,Amphotericin B,15629225,http://www.ncbi.nlm.nih.gov/pubmed/ 15629225,"Nooney L, Matthews RC, Burnie JP. (2005) Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. Diagn Microbiol Infect Dis. 51(1):19-29.",
nifedipine,Ketoconazole,15047538,http://www.ncbi.nlm.nih.gov/pubmed/ 15047538,"Afeltra J, Vitale RG, Mouton JW, Verweij PE. (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Chemother. 48(4):1335-43.",
nikkomycin X,Bifonazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,Clotrimazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,Fluconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,Itraconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,Ketoconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,Miconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,R 3783,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin X,ibuprofen,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, andagainst Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
nikkomycin Z,Anidulafungin,10952614,http://www.ncbi.nlm.nih.gov/pubmed/ 10952614,Stevens DA. (2000) Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob Agents Chemother. 44(9):2547-8.,
nikkomycin Z,Bupivacaine,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Clotrimazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Econazole,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
nikkomycin Z,Fluconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Ibuprofen,8592989,http://www.ncbi.nlm.nih.gov/pubmed/ 8592989,"Tariq VN, Scott EM, McCain NE. (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2615-9.",
nikkomycin Z,Itraconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Itraconazole,10348760,http://www.ncbi.nlm.nih.gov/pubmed/ 10348760,"Li RK, Rinaldi MG. (1999) In vitro antifungal activity ofin combination with fluconazole or itraconazole. Antimicrob Agents Chemother. 43(6):1401-5.",
nikkomycin Z,Ketoconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Micafungin,17325217,http://www.ncbi.nlm.nih.gov/pubmed/ 17325217,"Brun YF, Dennis CG, Greco WR, Bernacki RJ, Pera PJ, Bushey JJ, Youn RC, White DB, Segal BH. (2007) Modeling the combination of amphotericin B, micafungin, andagainst Aspergillus fumigatus in vitro using a novel response surface paradigm. Antimicrob Agents Chemother. 51(5):1804-12.",
nikkomycin Z,Micafungin,11709302,http://www.ncbi.nlm.nih.gov/pubmed/ 11709302,"Chiou CC, Mavrogiorgos N, Tillem E, Hector R, Walsh TJ. (2001) Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction betweenand the echinocandin FK463 against Aspergillus fumigatus. Antimicrob Agents Chemother. 45(12):3310-21.",
nikkomycin Z,Miconazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,R 3783,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nikkomycin Z,Bifonazole,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
nitric oxide,Fluconazole,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
nitric oxide,Ketoconazole,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
nitric oxide,Miconazole,9736560,http://www.ncbi.nlm.nih.gov/pubmed/9736560,"McElhaney-Feser GE, Raulli RE, Cihlar RL. (1998) Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob Agents Chemother. 42(9):2342-6.",
Ofloxacin,Fluconazole,11810556,http://www.ncbi.nlm.nih.gov/pubmed/11810556,"Sasaki E., Maesaki S., Miyazaki Y., Yanagihara K., Tomono K., Tashiro T., Kohno S. (2000) Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans. J Infect Chemother 6:151-4.",
Pentamidine,Amphotericin B,12234872,http://www.ncbi.nlm.nih.gov/pubmed/ 12234872,"Afeltra J, Dannaoui E, Meis JF, Rodriguez-Tudela JL, Verweij PE. (2002) In vitro synergistic interaction between amphotericin B andagainst Scedosporium prolificans. Antimicrob Agents Chemother. 46(10):3323-6.",
Pentamidine,Dacarbazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentamidine,Pentolinium,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentamidine,Phenazopyridine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentamidine,Ribavirin,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentamidine,Tamoxifen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470 ,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentolinium,Haloprogin,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentolinium,Sulconazole,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Pentolinium,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Perphenazine,Phenazopyridine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Perphenazine,Tamoxifen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenazopyridine,Phenelzine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenazopyridine,Dacarbazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenazopyridine,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenazopyridine,Fluconazole,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenazopyridine,Perphenazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenelzine,Tamoxifen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenelzine,Phenazopyridine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Phenelzine,Posaconazole,1,1,1,
Phenelzine,Voriconazole,1,1,1,
Posaconazole,Amphotericin B,21282457,http://www.ncbi.nlm.nih.gov/pubmed/ 21282457,"Chaturvedi V, Ramani R, Andes D, Diekema DJ, Pfaller MA, Ghannoum MA, Knapp C, Lockhart SR, Ostrosky-Zeichner L, Walsh TJ, Marchillo K, Messer S, Welshenbaugh AR, Bastulli C, Iqbal N, Paetznick VL, Rodriguez J, Sein T. (2011) Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother. 55(4):1543-8.",
Posaconazole,Amphotericin B,18458135,http://www.ncbi.nlm.nih.gov/pubmed/18458135,"Perkhofer S, Locher M, Cuenca-Estrella M, Rï¿½ï¿½chel R, Wï¿½ï¿½rzner R, Dierich MP, Lass-Fl?rl C. (2008)enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother. 52(7):2636-8.",
Posaconazole,Amphotericin B,15673745,http://www.ncbi.nlm.nih.gov/pubmed/ 15673745,"Cacciapuoti A, Gurnani M, Halpern J, Norris C, Patel R, Loebenberg D. (2005) Interaction betweenand amphotericin B in concomitant treatment against Candida albicans in vivo. Antimicrob Agents Chemother. 49(2):638-42.",
Posaconazole,Amphotericin B,17116665,http://www.ncbi.nlm.nih.gov/pubmed/ 17116665,"Perkhofer S, Lugger H, Dierich MP, Lass-Fl?rl C. (2007)enhances the activity of amphotericin B against Aspergillus hyphae in vitro. Antimicrob Agents Chemother. 51(2):791-3.",
Posaconazole,Caspofungin,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Posaconazole,Caspofungin,16048980,http://www.ncbi.nlm.nih.gov/pubmed/ 16048980,"Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, Redding SW. (2005) In vitro interaction ofand caspofungin against clinical isolates of Candida glabrata. Antimicrob Agents Chemother. 49(8):3544-5.",
Posaconazole,Caspofungin,17576835,http://www.ncbi.nlm.nih.gov/pubmed/17576835,"Guembe M, Guinea J, Pelï¿½ï¿½ez T, Torres-Narbona M, Bouza E. (2007) Synergistic effect ofand caspofungin against clinical zygomycetes. Antimicrob Agents Chemother. 51(9):3457-8.",
Posaconazole,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
Posaconazole,Flucytosine,11302795,http://www.ncbi.nlm.nih.gov/pubmed/ 11302795,"Barchiesi F, Schimizzi AM, Najvar LK, Bocanegra R, Caselli F, Di Cesare S, Giannini D, Di Francesco LF, Giacometti A, Carle F, Scalise G, Graybill JR. (2001) Interactions ofand flucytosine against Cryptococcus neoformans. Antimicrob Agents Chemother. 45(5):1355-9.",
Posaconazole,Terbinafine,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Posaconazole,Caspofungin,16048980,http://www.ncbi.nlm.nih.gov/pubmed/16048980,"Oliveira E.R., Fothergill A.W., Kirkpatrick W.R., Coco B.J., Patterson T.F., Redding S.W. (2005) In vitro interaction ofand caspofungin against clinical isolates of Candida glabrata. Antimicrobial Agents and Chemotherapy 49:3544-3545. DOI: 10.1128/aac.49.8.3544-3545.2005.",
Posaconazole,Rapamycin,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Posaconazole,Cyclosporine A,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Posaconazole,Phenelzine,1,1,1,
Propylparaben,Fluconazole,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
pyrazinamide,Fluconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
pyrazinamide,Itraconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
pyrazinamide,Voriconazole,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
R 3783,Nikkomycin X,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
R 3783,Nikkomycin Z,1416829,http://www.ncbi.nlm.nih.gov/pubmed/ 1416829,"Hector RF, Schaller K. (1992) Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother. 36(6):1284-9.",
rac-1-O-dodecylglycerol,Amphotericin B,7979283,http://www.ncbi.nlm.nih.gov/pubmed/ 7979283,"Haynes MP, Buckley HR, Higgins ML, Pieringer RA. (1994) Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers. Antimicrob Agents Chemother. 38(7):1523-9.",
Radicicol,Ketoconazole,17360571,http://www.ncbi.nlm.nih.gov/pubmed/17360571,"Zhang L.X., Yan K.Z., Zhang Y., Huang R., Bian J., Zheng C.S., Sun H.X., Chen Z.H., Sun N., An R., Min F.G., Zhao W.B., Zhuo Y., You J.L., Song Y.J., Yu Z.Y., Liu Z.H., Yang K.Q., Gao H., Dai H.Q., Zhang X.L., Wang J., Fu C.Z., Pei G., Liu J.T., Zhang S., Goodfellow M., Jiang Y.Y., Kuai J., Zhou G.C., Chen X.P. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proceedings of the National Academy of Sciences of the United States of America 104:4606-4611. DOI: 10.1073/pnas.0609370104.",
Ranalexin,Anidulafungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
Ranalexin,Caspofungin,20106636,http://www.ncbi.nlm.nih.gov/pubmed/ 20106636,"Harris MR, Coote PJ. (2010) Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. Int J Antimicrob Agents. 35(4):347-56.",
rapamycin,Amphotericin B,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
rapamycin,Amphotericin B,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E, Schwarz P, Lortholary O. (2009) In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. Antimicrob Agents Chemother. 53(8):3549-51.",
rapamycin,Fluconazole,18070977,http://www.ncbi.nlm.nih.gov/pubmed/ 18070977,"Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N. (2008) Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 52(2):735-8.",
rapamycin,Itraconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
rapamycin,Posaconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
rapamycin,Ravuconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
ravuconazole,Amphotericin B,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
ravuconazole,Terbinafine,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
ravuconazole,Terbinafine,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
ravuconazole,Cyclosporine,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
ravuconazole,Tacrolimus,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
ravuconazole,Rapamycin,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
ravuconazole,Anidulafungin,18195067,http://www.ncbi.nlm.nih.gov/pubmed/18195067,"Cuenca-Estrella M., Alastruey-Lzquierdo A., Alcazar-Fuoli L., Bernal-Martinez L., Gomez-Lopez A., Buitrago M.J., Mellado E., Rodriguez-Tudela J.L. (2008) In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrobial Agents and Chemotherapy 52:1136-1139. DOI: 10.1128/aac.01160-07",
ravuconazole,Cyclosporine A,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
ravuconazole,FK506,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Retigeric acid B,Ketoconazole,19171796,http://www.ncbi.nlm.nih.gov/pubmed/19171796,"Sun L.M., Sun S.J., Cheng A.X., Wu X.Z., Zhang Y., Lou H.X. (2009) In Vitro Activities of Retigeric Acid B Alone and in Combination with Azole Antifungal Agents against Candida albicans. Antimicrobial Agents and Chemotherapy 53:1586-1591. DOI: 10.1128/aac.00940-08.",
Retigeric acid B,Fluconazole,19171796,http://www.ncbi.nlm.nih.gov/pubmed/19171796,"Sun L.M., Sun S.J., Cheng A.X., Wu X.Z., Zhang Y., Lou H.X. (2009) In Vitro Activities of Retigeric Acid B Alone and in Combination with Azole Antifungal Agents against Candida albicans. Antimicrobial Agents and Chemotherapy 53:1586-1591. DOI: 10.1128/aac.00940-08.",
Ribavirin,Ketoconazole,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Ribavirin,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Rifabutin,Amphotericin B,9517924,http://www.ncbi.nlm.nih.gov/pubmed/ 9517924,"Clancy CJ, Yu YC, Lewin A, Nguyen MH. (1998) Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B. Antimicrob Agents Chemother. 42(3):509-13.",
rifampin,Bacitracin,2039211,http://www.ncbi.nlm.nih.gov/pubmed/ 2039211,"Bacon AE, McGrath S, Fekety R, Holloway WJ. (1991) In vitro synergy studies with Clostridium difficile. Antimicrob Agents Chemother. 35(3):582-3.",
Sodium Salicylate,Fluconazole,8592988,http://www.ncbi.nlm.nih.gov/pubmed/ 8592988,"Scott EM, Tariq VN, McCrory RM. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro. Antimicrob Agents Chemother. 39(12):2610-4.",
staurosporine,Caspofungin,15388447,http://www.ncbi.nlm.nih.gov/pubmed/ 15388447,"Markovich S, Yekutiel A, Shalit I, Shadkchan Y, Osherov N. (2004) Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob Agents Chemother. 48(10):3871-6.",
Sulconazole,Pentolinium,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Sulfamethoxazole,Caspofungin,15328085,http://www.ncbi.nlm.nih.gov/pubmed/15328085,"Yekutiel A, Shalit I, Shadkchan Y, Osherov N. (2004) In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 48(9):3279-83.",
Tacrolimus,Itraconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Tacrolimus,ravuconazole,19451295,http://www.ncbi.nlm.nih.gov/pubmed/19451295,"Dannaoui E., Schwarz P., Lortholary O. (2009) In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrobial Agents and Chemotherapy 53:3549-3551. DOI: 10.1128/aac.00184-09",
Tamoxifen,Methoxsalen,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Tamoxifen,Pentamidine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Tamoxifen,Perphenazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Tamoxifen,Phenelzine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Tamoxifen,Dacarbazine,12799470,http://www.ncbi.nlm.nih.gov/pubmed/12799470,"Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., Price E.R., Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., Keith C.T. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences of the United States of America 100:7977-7982. DOI: 10.1073/pnas.1337088100.",
Terbinafine,Amphotericin B,9511038,http://www.ncbi.nlm.nih.gov/pubmed/9511038,"Barchiesi F., Di Francesco L.F., Compagnucci P., Arzeni D., Giacometti A., Scalise G. (1998) In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. Journal of Antimicrobial Chemotherapy 41:59-65.",
Terbinafine,Caspofungin,19289531,http://www.ncbi.nlm.nih.gov/pubmed/19289531,"Cavalheiro A.S., Maboni G., de Azevedo M.I., Argenta J.S., Pereira D.I.B., Spader T.B., Alves S.H., Santurio J.M. (2009) In Vitro Activity of Terbinafine Combined with Caspofungin and Azoles against Pythium insidiosum. Antimicrobial Agents and Chemotherapy 53:2136-2138. DOI: 10.1128/aac.01506-08.",
Terbinafine,FK506,12604527,http://www.ncbi.nlm.nih.gov/pubmed/12604527,"Onyewu C., Blankenship J.R., Del Poeta M., Heitman J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrobial Agents and Chemotherapy 47:956-964. DOI: 10.1128/aac.47.3.956-964.2003.",
Terbinafine,Fluconazole,17332758,http://www.ncbi.nlm.nih.gov/pubmed/17332758,"Lehar J., Zimmermann G.R., Krueger A.S., Molnar R.A., Ledell J.T., Heilbut A.M., Short G.F., Giusti L.C., Nolan G.P., Magid O.A., Lee M.S., Borisy A.A., Stockwell B.R., Keith C.T. (2007) Chemical combination effects predict connectivity in biological systems. Molecular Systems Biology 3. DOI: 10.1038/msb4100116.",
Terbinafine,Itraconazole,10459811,http://www.ncbi.nlm.nih.gov/pubmed/10459811,"Barchiesi F., Gallo D., Caselli F., Di Francesco L.F., Arzeni D., Giacometti A., Scalise G. (1999) In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans. Journal of Antimicrobial Chemotherapy 44:65-70.",
Terbinafine,Ketoconazole,12499177,http://www.ncbi.nlm.nih.gov/pubmed/12499177,"Meletiadis J., Mouton J.W., Meis J., Verweij P.E. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates. Antimicrobial Agents and Chemotherapy 47:106-117. DOI: 10.1128/aac.47.1.106-117.2003.",
Terbinafine,Miconazole,17332758,http://www.ncbi.nlm.nih.gov/pubmed/17332758,"Lehar J., Zimmermann G.R., Krueger A.S., Molnar R.A., Ledell J.T., Heilbut A.M., Short G.F., Giusti L.C., Nolan G.P., Magid O.A., Lee M.S., Borisy A.A., Stockwell B.R., Keith C.T. (2007) Chemical combination effects predict connectivity in biological systems. Molecular Systems Biology 3. DOI: 10.1038/msb4100116.",
Terbinafine,Voriconazole,12499177,http://www.ncbi.nlm.nih.gov/pubmed/12499177,"Meletiadis J., Mouton J.W., Meis J., Verweij P.E. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedospotium prolificans isolates. Antimicrobial Agents and Chemotherapy 47:106-117. DOI: 10.1128/aac.47.1.106-117.2003.",
Terbinafine,6-amino-2-n-pentylthiobenzothiazole,10854813,http://www.ncbi.nlm.nih.gov/pubmed/10854813,"Mï¿½ï¿½ckovï¿½ï¿½ M, Bujdï¿½ï¿½kovï¿½ï¿½ H, Kuchta T. (2000) Synergy between 6-amino-2-n-pentylthiobenzothiazole and ergosterol biosynthesis-inhibiting antimycotics against Candida albicans in vitro. Int J Antimicrob Agents. 15(2):153-4.",
Terbinafine,Albaconazole,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Terbinafine,Amphotericin B,12121963,http://www.ncbi.nlm.nih.gov/pubmed/ 12121963,"Dannaoui E, Afeltra J, Meis JF, Verweij PE; Eurofung Network. (2002) In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother. 46(8):2708-11.",
Terbinafine,Caspofungin,15120736,http://www.ncbi.nlm.nih.gov/pubmed/ 15120736,"Gil-Lamaignere C, Mï¿½ï¿½ller FM. (2004) Differential effects of the combination of caspofungin andagainst Candida albicans, Candida dubliniensis and Candida kefyr. Int J Antimicrob Agents. 23(5):520-3.",
Terbinafine,Caspofungin,19289531,http://www.ncbi.nlm.nih.gov/pubmed/ 19289531,"Cavalheiro AS, Maboni G, de Azevedo MI, Argenta JS, Pereira DI, Spader TB, Alves SH, Santurio JM. (2009) In Vitro activity ofcombined with caspofungin and azoles against Pythium insidiosum. Antimicrob Agents Chemother. 53(5):2136-8.",
Terbinafine,Fluconazole,19289531,http://www.ncbi.nlm.nih.gov/pubmed/ 19289531,"Cavalheiro AS, Maboni G, de Azevedo MI, Argenta JS, Pereira DI, Spader TB, Alves SH, Santurio JM. (2009) In Vitro activity ofcombined with caspofungin and azoles against Pythium insidiosum. Antimicrob Agents Chemother. 53(5):2136-8.",
Terbinafine,Itraconazole,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Terbinafine,Itraconazole,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. Feb;31(2):171-4.",
Terbinafine,Itraconazole,12663160,http://www.ncbi.nlm.nih.gov/pubmed/12663160,"Dunn JJ, Billetdeaux E, Skodack-Jones L, Carroll KC. (2003) Evaluation of three Copan viral transport systems for the recovery of cultivatable, clinical virus isolates. Diagn Microbiol Infect Dis. 45(3):191-7.",
Terbinafine,Itraconazole,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles withagainst clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Terbinafine,Itraconazole,10639389,http://www.ncbi.nlm.nih.gov/pubmed/ 10639389,"Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. (2000) In vitro interaction ofwith itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother. 44(2):470-2.",
Terbinafine,Itraconazole,11850251,http://www.ncbi.nlm.nih.gov/pubmed/11850251,"Te Dorsthorst DT, Verweij PE, Meis JF, Punt NC, Mouton JW. (2002) Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother. 46(3):702-7.",
Terbinafine,miconazole,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles withagainst clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Terbinafine,Posaconazole,16723597,http://www.ncbi.nlm.nih.gov/pubmed/16723597,"Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL. (2006) In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrob Agents Chemother. 50(6):2248-50.",
Terbinafine,Ravuconazole,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Terbinafine,Ravuconazole,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
Terbinafine,Voriconazole,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Terbinafine,Voriconazole,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
Terbinafine,Voriconazole,12121963,http://www.ncbi.nlm.nih.gov/pubmed/ 12121963,"Dannaoui E, Afeltra J, Meis JF, Verweij PE; Eurofung Network. (2002) In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother. 46(8):2708-11.",
Terbinafine,Voriconazole,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. Feb;31(2):171-4.",
Terbinafine,Voriconazole,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles withagainst clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Tetracycline,Amphotericin B,18310042,http://www.ncbi.nlm.nih.gov/pubmed/18310042,"Oliver B.G., Silver P.M., Marie C., Hoot S.J., Leyde S.E., White T.C. (2008) Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology-Sgm 154:960-970.",
trimethoprim,Atovaquone,9021174,http://www.ncbi.nlm.nih.gov/pubmed/ 9021174,"Walzer PD, Runck J, Orr S, Foy J, Steele P, White M. (1997) Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies. Antimicrob Agents Chemother. 41(2):242-50.",
Tunicamycin,Cyclosporine A,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Tunicamycin,FK506,20029371,http://www.ncbi.nlm.nih.gov/pubmed/20029371,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
Voriconazole,Amiodarone,18006280,http://www.ncbi.nlm.nih.gov/pubmed/ 18006280,"Guo Q, Sun S, Li Y, Yu J, Shi C. (2008) In vitro interactions between azoles and amiodarone against clinical Candida albicans. Int J Antimicrob Agents. 31(1):88-90.",
Voriconazole,Amphotericin B,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B, caspofungin andagainst clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Voriconazole,Amphotericin B,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. 31(2):171-4.",
Voriconazole,Anidulafungin,19995928,http://www.ncbi.nlm.nih.gov/pubmed/ 19995928,"Meletiadis J, Pournaras S, Roilides E, Walsh TJ. (2010) Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus. Antimicrob Agents Chemother. 54(2):602-9.",
Voriconazole,Anidulafungin,16048988,http://www.ncbi.nlm.nih.gov/pubmed/16048988,"Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. (2005) In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 49(8):3572-4.",
Voriconazole,Anidulafungin,19307368,http://www.ncbi.nlm.nih.gov/pubmed/19307368,"Petraitis V, Petraitiene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Schaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. (2009) Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin andby Bliss independence drug interaction analysis. Antimicrob Agents Chemother. 53(6):2382-91.",
Voriconazole,Caspofungin,18299413,http://www.ncbi.nlm.nih.gov/pubmed/ 18299413,"Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ. (2008) Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother. 52(6):2196-204.",
Voriconazole,Caspofungin,15728937,http://www.ncbi.nlm.nih.gov/pubmed/ 15728937,"Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL. (2005) Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 49(3):1232-5.",
Voriconazole,Caspofungin,20194697,http://www.ncbi.nlm.nih.gov/pubmed/ 20194697,"Kiraz N, Dag I, Yamac M, Kiremitci A, Kasifoglu N, Oz Y. (2010) Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods. Antimicrob Agents Chemother. 54(5):2244-7.",
Voriconazole,Caspofungin,20202797,http://www.ncbi.nlm.nih.gov/pubmed/ 20202797,"Li H, Lu Q, Wan Z, Zhang J. (2010) In vitro combined activity of amphotericin B, caspofungin andagainst clinical isolates of Trichosporon asahii. Int J Antimicrob Agents. 35(6):550-2.",
Voriconazole,Ethambutol,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Voriconazole,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/ 14506059,"Schwarz P, Dromer F, Lortholary O, Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 47(10):3361-4.",
Voriconazole,Itraconazole,15855543,http://www.ncbi.nlm.nih.gov/pubmed/ 15855543,"Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. (2005) Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother. 49(5):2119-21.",
Voriconazole,Lovastatin,16377673,http://www.ncbi.nlm.nih.gov/pubmed/ 16377673,"Chamilos G, Lewis RE, Kontoyiannis DP. (2006) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother. 50(1):96-103.",
Voriconazole,Micafungin,16304192,http://www.ncbi.nlm.nih.gov/pubmed/16304192,"Heyn K, Tredup A, Salvenmoser S, Mï¿½ï¿½ller FM. (2005) Effect ofcombined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother. 49(12):5157-9.",
Voriconazole,Micafungin,15980382,http://www.ncbi.nlm.nih.gov/pubmed/ 15980382,"Serena C, Fernï¿½ï¿½ndez-Torres B, Pastor FJ, Trilles L, Lazï¿½ï¿½ra Mdos S, Nolard N, Guarro J. (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother. 49(7):2994-6.",
Voriconazole,Pyrazinamide,19520551,http://www.ncbi.nlm.nih.gov/pubmed/ 19520551,"Cordeiro Rde A, Brilhante RS, Rocha MF, Medrano DJ, Monteiro AJ, Tavares JL, de Lima RA, de Camargo ZP, Sidrim JJ. (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int J Antimicrob Agents. 34(3):278-80.",
Voriconazole,Terbinafine,15215136,http://www.ncbi.nlm.nih.gov/pubmed/15215136,"Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J. (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother. 48(7):2727-9.",
Voriconazole,Terbinafine,14761725,http://www.ncbi.nlm.nih.gov/pubmed/ 14761725,"Ortoneda M, Capilla J, Javier Pastor F, Pujol I, Guarro J. (2004) In vitro interactions of licensed and novel antifungal drugs against Fusarium spp. Diagn Microbiol Infect Dis. 48(1):69-71.",
Voriconazole,Terbinafine,12121963,http://www.ncbi.nlm.nih.gov/pubmed/ 12121963,"Dannaoui E, Afeltra J, Meis JF, Verweij PE; Eurofung Network. (2002) In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother. 46(8):2708-11.",
Voriconazole,Terbinafine,18054469,http://www.ncbi.nlm.nih.gov/pubmed/ 18054469,"Cï¿½ï¿½rdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.. (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. Feb;31(2):171-4.",
Voriconazole,Terbinafine,12499177,http://www.ncbi.nlm.nih.gov/pubmed/ 12499177,"Meletiadis J, Mouton JW, Meis JF, Verweij PE. (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother. 47(1):106-17.",
Voriconazole,FK506,18056277,http://www.ncbi.nlm.nih.gov/pubmed/18056277,"Sun S., Li Y., Guo Q.J., Shi C.W., Yu J.L., Ma L. (2008) In vitro interactions between tacrolimus and Azoles against Candida albicans determined by different methods. Antimicrobial Agents and Chemotherapy 52:409-417. DOI: 10.1128/aac.01070-07.",
Voriconazole,Micafungin,19280292,http://www.ncbi.nlm.nih.gov/pubmed/19280292,"Nishi I., Sunada A., Toyokawa M., Asari S., Iwatani Y. (2009) In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species (vol 15, pg 1, 2009). Journal of Infection and Chemotherapy 15:123-124. DOI: 10.1007/s10156-009-0002-7",
Voriconazole,Terbinafine,111181393,http://www.ncbi.nlm.nih.gov/pubmed/11181393,"Weig M., Muller F.M.C. (2001) Synergism ofand terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrobial Agents and Chemotherapy 45:966-968.",
Voriconazole,Cyclosporine A,18194958,http://www.ncbi.nlm.nih.gov/pubmed/18194958,"Li Y., Sun S.J., Guo Q.J., Ma L., Shi C.W., Su L.Q., Li H.J. (2008) In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. Journal of Antimicrobial Chemotherapy 61:577-585. DOI: 10.1093/jac/dkm493.",
Voriconazole,Flucytosine,14506059,http://www.ncbi.nlm.nih.gov/pubmed/14506059,"Schwarz P., Dromer F., Lortholary O., Dannaoui E. (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrobial Agents and Chemotherapy 47:3361-3364. DOI: 10.1128/aac.47.10.3361-3364.2003",
Voriconazole,Phenelzine,1,1,1,
Wortmannin,Fluconazole,17332758,http://www.ncbi.nlm.nih.gov/pubmed/17332758,"Jansen G., Lee A.Y., Epp E., Fredette A., Surprenant J., Harcus D., Scott M., Tan E., Nishimura T., Whiteway M., Hallett M., Thomas D.Y. (2009) Chemogenomic profiling predicts antifungal synergies. Molecular Systems Biology 5. DOI: 10.1038/msb.2009.95.",
